Vita Coco (NASDAQ: COCO) director Ira Liran reports 50,000-share stock sale

Rhea-AI Filing Summary

Vita Coco Company, Inc. director Ira Liran reported planned stock sales under a Rule 10b5-1 trading plan. On February 5, 2026, he sold 20,000 shares of common stock directly at a weighted average price of $56.66, leaving 478,341 shares held directly.

On the same date, an additional 30,000 shares of common stock were sold indirectly at a weighted average price of $56.65, with 572,579 shares held indirectly by the Ira Liran 2012 Family Trust. Both reported prices reflect multiple trades within stated intraday price ranges.

Insider Trade Summary

Net Seller: 50,000 shares ($2,832,700)

Net Sell 2 txns

Insider Liran Ira

Role Director

Sold 50,000 shs ($2.83M)

Type	Security	Shares	Price	Value
Sale	Common Stock	20,000	$56.66	$1.13M
Sale	Common Stock	30,000	$56.65	$1.70M

Holdings After Transaction: Common Stock — 478,341 shares (Direct); Common Stock — 572,579 shares (Indirect, by Ira Liran 2012 FT)

Footnotes (1)

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.48 to $57.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.70 to $57.36, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These shares are held by the Ira Liran 2012 Family Trust.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liran Ira

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/05/2026		S(1)		20,000	D	$56.66(2)	478,341	D
Common Stock	02/05/2026		S(1)		30,000	D	$56.65(3)	572,579	I	by Ira Liran 2012 FT(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.48 to $57.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.70 to $57.36, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

4. These shares are held by the Ira Liran 2012 Family Trust.

	/s/ Alison Klein, attorney-in-fact for Ira Liran	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did COCO director Ira Liran report on February 5, 2026?

Director Ira Liran reported selling 50,000 Vita Coco common shares on February 5, 2026. The filing shows 20,000 shares sold directly and 30,000 sold indirectly through the Ira Liran 2012 Family Trust under a pre-arranged Rule 10b5-1 trading plan.

At what prices were the Vita Coco (COCO) shares sold in Ira Liran’s Form 4 filing?

The reported weighted average prices were $56.66 for 20,000 directly held shares and $56.65 for 30,000 indirectly held shares. Each weighted price reflects multiple trades within ranges of $54.48–$57.33 and $54.70–$57.36, respectively, as disclosed.

How many Vita Coco (COCO) shares does Ira Liran hold after the reported transactions?

After the trades, Ira Liran beneficially owns 478,341 Vita Coco shares directly. Indirectly, 572,579 shares are held by the Ira Liran 2012 Family Trust. These post-transaction balances are reported in the Form 4 for the February 5, 2026 sales.

What is the role of the Ira Liran 2012 Family Trust in the COCO insider transactions?

The Ira Liran 2012 Family Trust holds Vita Coco shares indirectly for Ira Liran. In this Form 4, 30,000 common shares were sold from the trust’s holdings, and 572,579 shares remain beneficially owned indirectly through the trust after the reported transactions.

Were Ira Liran’s Vita Coco (COCO) stock sales pre-planned under Rule 10b5-1?

Yes. The filing states that the sales of Vita Coco common stock were effected pursuant to a Rule 10b5-1 trading plan. Such plans allow insiders to schedule trades in advance, providing a structured framework for selling shares over time.

How are the transaction prices in Ira Liran’s COCO Form 4 calculated?

The prices shown are weighted average sale prices for each transaction line. The Form 4 notes that actual trades occurred in multiple individual transactions within specified price ranges and that detailed trade-by-trade information is available upon request from the issuer or regulators.